IDAC Theranostics, Inc.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C07K PEPTIDES 2134
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1254
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0328,887 METHOD FOR ASSESSING THERAPEUTIC EFFECT OF ANTI-CANCER AGENT HAVING ANTI-CD4 ANTIBODY AS ACTIVE INGREDIENTDec 02, 15Nov 16, 17[G01N]
2017/0165,364 THERAPEUTIC AGENT FOR SOLID CANCERFeb 09, 15Jun 15, 17[A61K, C07K]
2017/0166,959 Method For Analyzing Nucleic Acid Derived From Single CellApr 07, 15Jun 15, 17[C12Q]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8278427 Molecule for assigning genotype to phenotype and components thereof as well as method for constructing assigning molecule and method for utilizing assigning moleculeJun 13, 03Oct 02, 12[C07H, A61K, C12N]
7150978 Recombinant template used for producing a carboxy-terminal modified protien and a method of producing a carboxy-terminal modified proteinJun 06, 03Dec 19, 06[C12P]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0108,122 THERAPEUTIC OR PROPHYLACTIC AGENT FOR IMMUNODEFICIENCY VIRUS INFECTIONAbandonedMay 23, 14Apr 21, 16[C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.